Parinaz Ghaswalla, PhD, is a Health Outcomes and Epidemiology Scientist at GlaxoSmithKline Vaccines, where she leads epidemiology and health economics research studies across multiple infectious disease areas, such as meningococcal meningitis, hepatitis A and B, herpes zoster, influenza, pertussis and rotavirus disease. Parinaz has extensive experience designing retrospective studies utilizing a wide variety of real-world US data sources such as administrative insurance claims, large national surveys, and medical records review, as well as in designing prospective studies, including pharmacy practice-based implementation research projects. Prior to joining GSK in 2017, Parinaz was a healthcare consultant at a Washington DC-based health care research and consulting firm, where her research focused on analysis of payer and provider-related health care policy trends with application to the pharmaceutical industry and the US healthcare system. She received her PhD in Pharmacotherapy and Outcomes Sciences from Virginia Commonwealth University in 2011.
Disclosure: GlaxoSmithKline (Individual(s) Involved: Self): Employee, Shareholder